{"id":81629,"date":"2025-01-15T09:26:02","date_gmt":"2025-01-15T08:26:02","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?post_type=resources&#038;p=81629"},"modified":"2026-07-01T15:41:37","modified_gmt":"2026-07-01T13:41:37","slug":"building-a-compliant-content-foundation-for-the-future","status":"publish","type":"resources","link":"https:\/\/www.veeva.com\/eu\/resources\/building-a-compliant-content-foundation-for-the-future\/","title":{"rendered":"Building a Compliant Content Foundation <br class=\"hidden-xs\">for the Future"},"content":{"rendered":"<style>\n.veeva-2024 .fa-ul li p {\nmargin-top:5px;\n}\n.veeva-2024 .content-block .fa-check-circle {\ncolor: #f7981d;\nfont-weight: 400;\nfont-size:20px;\n}\n@media (min-width:768px) {\n.veeva-2024 .hero-centered {\npadding: 100px 0;\n}<\/p>\n<p>.veeva-2024 .content-block__content .stat-box {\nbackground: #eef1f5;\ndisplay: inline-block;\npadding: 10px 30px;\nborder-radius: 16px;\nfont-size: 18px;\nmargin: 5px 5px 20px 5px;\nfont-weight: 500;\n}\n.veeva-2024 .content-block__content .stat-box span {\ncolor:#f5670e;\nfont-weight:600;\n}<\/p>\n<p>.veeva-2024 .form-dropdown {\ndisplay: none;\n}\n<\/style>\n<p>Over the last decade, emerging biotechs have branched out from historically<br \/>\ncommon licensing, partnership, and acquisition paths to launch products<br \/>\nthemselves. In fact, <a href=\"https:\/\/www.mckinsey.com\/industries\/life-sciences\/our-insights\/making-the-leap-from-r-and-d-to-fully-integrated-biotech-for-first-launch\" target=\"_blank\" rel=\"noopener noreferrer\">industry data<\/a> shows that first-time biotechs outnumber established companies in launching new products by more than two to one. For many emerging biopharmas, preparing for launch means focusing attention on essential foundational content areas.<\/p>\n<p>For many emerging biopharmas, preparing for launch means focusing attention on essential foundational content areas. The quality and compliance of the foundation you lay for your content workflows now \u2014 including medical, legal, and regulatory (MLR) review processes \u2014 can create a competitive edge and help your organization scale more efficiently in the future.<\/p>\n<div class=\"text-center\">\n<div class=\"stat-box\">\n   <span>25%<\/span> reduction in time spent<br \/> on compliance procedures\n<\/div>\n<div class=\"stat-box\">\n   <span>57%<\/span> reduction in <br \/>review cycle times\n<\/div>\n<div class=\"stat-box\">\n   <span>55%<\/span> reduction in time spent <br \/>in MLR\/PRC meetings\n<\/div>\n<\/div>\n<h2>Compliant content management optimizes review and approval<\/h2>\n<p>Speed is critical to maintaining launch timelines, but moving too quickly can lead to costly mistakes. In 2025, life sciences companies in the U.S. paid roughly <a href=\"https:\/\/www.justice.gov\/opa\/pr\/false-claims-act-settlements-and-judgments-exceed-68b-fiscal-year-2025\" target=\"_blank\" rel=\"noopener noreferrer\">$6.8 billion<\/a> to settle False Claims Act violations and off-label promotions.<\/p>\n<p>The right foundation for MLR review and approval reduces the risk of fines while increasing speed and efficiency. Along with improved compliance through a clear chain of custody and automated audit trails,<br \/>\n<a href=\"\/eu\/products\/veeva-promomats\/\">³Ô¹Ï±¬ÁÏ PromoMats<\/a> users reported a 25% reduction in time spent on compliance procedures.<\/p>\n<blockquote><p>\n&#8220;We\u2019re trying to be transformative, but we have to lay the foundation first.&#8221;<br \/>\n<span>Robert Yee, Senior Product Manager, Azurity Pharmaceuticals<\/span>\n<\/p><\/blockquote>\n<h2>Build an AI-Ready Content Foundation<\/h2>\n<p>Emerging biopharmas commonly use email and spreadsheets as a starting point to manage MLR reviews and approvals. However, these systems are highly manual and time-consuming, so it\u2019s easy to lose track of where an asset stands in the review process. The result: a drain on your organization\u2019s limited resources and increased compliance risks.<\/p>\n<p>A more sustainable option is to automate these cycles through a dedicated MLR review system. With review and approval tracked in one place, your stakeholders can manage approval queues and gain visibility into content moving down the pipeline. Meanwhile, you can quickly identify and address any bottlenecks in the process. Organizations with streamlined MLR processes in ³Ô¹Ï±¬ÁÏ PromoMats report a 57% reduction in review cycle times and a 55% reduction in review meeting duration, advancing speed and compliance.<\/p>\n<p>Crucially, establishing this streamlined workflow today creates the foundation necessary to support AI innovation as your team scales. Vault AI in PromoMats operates in tandem with these foundational capabilities. By leveraging purpose-built agents, teams can automate routine checks and reduce manual back-and-forth. This integrated approach ensures the fastest path to approved content for your immediate launch, while empowering your organization to adopt new, industry-specific AI capabilities as your needs evolve.<\/p>\n<h2>Modern claims management enables launch efficiency<\/h2>\n<p>Manual processes like tagging and anchoring claims to supporting references are not only time-consuming but also prone to human error. As you navigate peak content volumes and aggressive deadlines during launch, there\u2019s no room for delays. A modern approach to claims management can help your organization avoid slowdowns and maintain compliance with the automation of repetitive tasks, clear audit trails, and traceability.<\/p>\n<blockquote><p>\n&#8220;By using a core technology solution, we have a single source of truth for approved content and the ability to flex and optimize our MLR workflows as the company evolves.&#8221;<br \/>\n<span>Martin Boyle, Senior Director of Field and Marketing Operations, Regeneron<\/span>\n<\/p><\/blockquote>\n<p>Use modern claims management to optimize your content operations by automatically tagging and linking materials to approved claims. And when you stand up a central claims library, your stakeholders gain access to standardized language, improved transparency, and accurate documentation. Building on this foundation, Vault AI in PromoMats will significantly accelerate this workflow. Upcoming AI capabilities purpose-built for claims management will automate key tasks in the process, enabling lean teams to handle peak launch volumes while ensuring every piece of promotional content is properly substantiated with speed, accuracy, and confidence.<\/p>\n<blockquote><p>\n&#8220;80% of our claims are now linked automatically. This automation has significantly cut down manual linking, which used to take 10 minutes per claim, and now constitutes only about 20% of the overall process.&#8221;<br \/>\n<span>Senior Marketing Director, Emerging Biotech<\/span>\n<\/p><\/blockquote>\n<h2>Anticipating and preparing for future challenges<\/h2>\n<h3>Establishing a standardized content taxonomy from the start<\/h3>\n<p>Emerging biotechs that implement a standard taxonomy while building a content foundation can avoid future disconnects with channels, intent, and format. It provides a standard content hierarchy, classification, and description for organizing and delivering content.<\/p>\n<p>As an emerging biotech, adopting the Commercial Content Kernel from the start will help you increase speed, efficiency, and quality of data management for your organization in the future. When content operations scale, you\u2019ll be able to locate, manage, and repurpose materials much more easily and efficiently.<\/p>\n<h2>Adopting a comprehensive, connected solution<\/h2>\n<p>Traditional content methods \u2014 siloed systems or paper-based processes \u2014 can delay content availability and create compliance risks. The integration of PromoMats with other ³Ô¹Ï±¬ÁÏ solutions, such as <a href=\"\/eu\/products\/veeva-rim\/\">³Ô¹Ï±¬ÁÏ RIM<\/a>, <a href=\"\/eu\/products\/medical-solutions\/\">Medical Suite<\/a>, and <a href=\"\/eu\/products\/crm-suite\/\">Vault CRM<\/a>, creates a connected ecosystem that enhances content management across the end-to-end lifecycle.<\/p>\n<blockquote><p>\n&#8220;With ³Ô¹Ï±¬ÁÏ PromoMats, we can easily collaborate, share, and integrate digital content across our ³Ô¹Ï±¬ÁÏ ecosystem. This drives success right out the gate because we immediately gain valuable insights to inform more efficient content production and can implement changes quickly, as needed.&#8221;<br \/>\n<span>Associate Director, IT Product Manager, Biotech <\/span>\n<\/p><\/blockquote>\n<p>These connections allow for seamless data flow between different systems, ensuring that content is compliant and of the highest quality throughout creation, review, approval, and distribution.<\/p>\n<p><a href=\"mailto:joe.adams.comms@veeva.com \">Schedule a call<\/a>  with Joe Adams, Strategy Director, Commercial Content Europe, to discuss your content strategy and learn why 450+ emerging and mid-size biotechs use PromoMats to build a compliant content foundation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Why biotechs preparing for launch need a compliant content foundation.<\/p>\n","protected":false},"featured_media":81631,"parent":0,"template":"","class_list":["post-81629","resources","type-resources","status-publish","has-post-thumbnail","hentry","resource-html-content-yes","resource-area-20-commercial","resource-product-20-commercial-content-promomats","resource-type-white-papers","region-fr"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/81629"}],"collection":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/types\/resources"}],"version-history":[{"count":3,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/81629\/revisions"}],"predecessor-version":[{"id":98641,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/resources\/81629\/revisions\/98641"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media\/81631"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/eu\/wp-json\/wp\/v2\/media?parent=81629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}